Fatal alveolar hemorrhage and Abciximab (ReoPro(TM)) therapy for acute myocardial infarction

Catheterization and Cardiovascular Diagnosis

Volumn 44, Issue 3, 1998, Pages 313-316

  Khanlou, Homayoun ^a   Tsiodras, Sotirios ^a   Eiger, Glenn ^a   Abousy, Khalid ^a   Goldberg, Steven ^a   Nakhjavan, Fred ^a   Yazdanfar, Shahriar ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Abciximab ReoPro(TM); ARDS; Cardiac catheterization; Intracoronary thrombosis; Pulmonary hemorrhage

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; PROSTACYCLIN; TICLOPIDINE;

AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; CENTRAL VENOUS PRESSURE; HEART CATHETERIZATION; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CAPILLARY PRESSURE; LUNG HEMORRHAGE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESPIRATORY DISTRESS; STENT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; FATAL OUTCOME; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LUNG DISEASES; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PULMONARY ALVEOLI; RADIOGRAPHY, THORACIC; RESPIRATORY DISTRESS SYNDROME, ADULT; STENTS;

EID: 0031803925     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199807)44:3<313::AID-CCD14>3.0.CO;2-L     Document Type: Article

References (11)

1. Coller BS: A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 76:101-108, 1985.
2. The EPIC Investigators: Prevention of ischemic complications in high-risk angioplasty by a chimeric monoclonal antibody c7E3 Fab fragment directed against the platelet glycoprotein IIb/IIIa receptor. N Engl J Med 330:956-61, 1994.
3. Topol JE, Califf MR, Weisman FH, et al. (on behalf of the EPIC investigators): Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 343:881-886, 1994.
4. Aguirre F, Topol E, Ferguson J, Anderson K, et al. (on behalf of the EPIC Investigators): Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa Integrin in patients undergoing percutaneous coronary intervention. Circulation 91: 2882-2890, 1995.
5. Awadh N, Ronco JJ, Bernstein V, Gilks B, Wilcox P: Spontaneous pulmonary hemorrhage after thrombolytic therapy for acute myocardial infarction. Chest 106:1622-1624, 1994.
6. Albelda SM, Gefter WB, Epstein DM, Miller WT: Diffuse pulmonary hemorrhage: A review and classification. Radiology 154:289-297, 1985.
7. Gopalakrishnan D, Tioran T, Emanuel C, Clark VL: Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Clin Cardiol 20:298-300, 1997.
8. ISIS-2 Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction (ISIS-2). Lancet 318:349-360, 1988.
9. Hass WK, Easton JD, Adams HP, et al.: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 321:501-507, 1989.
10. Balsano F, Rizzon P, Violi F, et al.: Antiplatelet treatment with Ticlopidine in unstable angina: A controlled multicenter clinical trial. Circulation 82:17-26, 1990.
11. Di Minno G, Cerbone AM, Mattioli PL, et al.: Functionally thrombasthenic state in normal platelets following the administration of Ticlopidine. J Clin Invest 75:328-338, 1985.